Correction to: Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle? (Clinical Reviews in Allergy & Immunology, (2026), 69, 1, (3), 10.1007/s12016-025-09131-5)

Correction to: Clinical Reviews in Allergy & Immunology (2026) 69:3. https://doi.org/10.1007/s12016-025-09131-5. In this article, part of the caption for Figure 1 was mistakenly misplaced as the last paragraph in the ‘Conclusion’ section. The figure caption should have appeared as shown below. (Figure presented.) Graphical depiction of local and remote priming. Infant epicutaneous sensitization, or local priming, can occur through a combination epidermal damage, type 2 signaling and food antigen exposure. Epidermal damage is associated with alarmin signals (IL-33, IL-25 and TLSP) and ILC2 cytokines. Together, these promote DCs to educate memory T and B lymphocytes in a ‘danger’ context, thereby recognizing food antigens as allergens, resulting in the loading of skin-resident mast cells with allergen-specific antibodies. DCs and tissues also produce chemotactic agents such as CCL-17 enhancing the recruitment of type 2 effector cells from the circulation. Remote gut priming is thought to be initiated primarily with epidermal IL-33 binding of ST2 on ILC2s in a nonredundant manner for optimal distal IgE production. The role of ILC2s in this process may involve distinct mechanisms; 1-upstream of effector T cell generation by influencing DC migration or activation, 2-contribution to mast cell expansion in the intestine and 3-within lymphoid organs to complement the IL-4 and IL-13 primarily derived from T follicular helper (TFH) cells, thereby further enhancing B cell class switching to IgE. Gut resident mast cells are ultimately loaded with food-allergen specific IgE, primed for food allergen recognition and degranulation upon subsequent oral exposure. Created in Biorender [66]. The original article has been corrected.